Le Lézard
Classified in: Mining industry, Science and technology, Business
Subject: OTC

New Market for Lithium Exploration Group Technology Created by Estimated $3.8 Billion Expense to Energy Industry Resulting from Canadian Emissions Regulatory Crackdown


TEMPE, Arizona, May 31, 2017 /PRNewswire/ --

Lithium Exploration Group Inc. (USOTC: LEXG) announced today that the Canadian Government has released an outline of new restrictions on the Canadian energy industry to promote more frequent equipment inspections, repair mandates, the use of cleaner technologies, and closer emission level monitoring.  Lithium Exploration Group can resolve all the new regulatory restrictions with its Sonic Cavitation LTD Technology solution suite when it comes to treating and heating produced hydrocarbons.

Lithium Exploration Group CEO Alex Walsh:

"The focus of this regulation is to force the energy industry to adopt new practices utilizing new technologies that are cleaner and greener than the status quo. Unfortunately the common mentality of the energy industry is 'if it ain't broke don't fix it' - fortunately for us the Canadian Government is telling the energy industry 'it is broke so go fix it. These changes are set to take place in 2020 which allows us plenty of time to get sales and distribution efforts in place and take the industry by storm."

About Lithium Exploration Group

Lithium Exploration Group is a US-based exploration and development company focused on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. Currently the company is focused testing its SonCav Technology and the acquisition of oil and gas related assets in the US and Canada. Lithium Exploration Group is traded on the OTC Markets under the symbol LEXG.

Website: http://www.lithiumexplorationgroup.com .

Safe Harbor Statement

This news release contains "forward-looking statements". Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future testing of the ultrasonic technology.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of lithium prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements.

Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact Info
Shanon Chilson
+1-480-641-4790
[email protected]

SOURCE Lithium Exploration Group Inc.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: